Personalized Gene Therapy Treatment Market Forecast: What to Expect by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Personalized Gene Therapy Treatment Market From 2025 To 2034?

The personalized gene therapy treatment market has seen significant expansion in recent years. It is projected to expand from $6.93 billion in 2024 to $8.38 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 20.8%. This historical growth can be attributed to the increasing incidence of genetic disorders, advancements in gene editing technologies, heightened awareness about personalized medicine, supportive government initiatives and funding, and the development of biotechnology research and infrastructure.

The personalized gene therapy treatment market size is projected to experience rapid expansion over the coming years. This market is set to reach $17.65 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 20.5%. Several factors will drive this growth during the forecast period, including the broadening scope of clinical trials for gene therapies, the incorporation of AI and predictive analytics into treatment formulation, a rise in collaborations between pharmaceutical and biotechnology firms, the creation of more secure and effective delivery vectors, and the increasing need for targeted and precision therapies. Key trends anticipated during this period encompass the integration of artificial intelligence and machine learning in therapy development, an increase in genomic sequencing capacities, growing cooperation between biotechnology and pharmaceutical enterprises, the automation of gene therapy production methods, and the adoption of blockchain technology to secure genetic data.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28293&type=smp

What Are The Top Growth Drivers Impacting The Personalized Gene Therapy Treatment Market Outlook?

The increasing occurrence of genetic conditions is anticipated to fuel the expansion of the personalized gene therapy treatment market in the future. These disorders stem from irregularities in DNA, which impair typical bodily functions. The rising incidence of genetic disorders is linked to the growing age of parents, given that older reproductive cells are more prone to mutations that can be inherited by their children. Personalized gene therapy offers a solution to genetic disorders by accurately rectifying the faulty genes causing the ailment, thereby customizing treatment to an individual’s unique genetic profile, which boosts effectiveness and minimizes adverse reactions. An example of this trend can be seen in the UK, where, as reported by the Cystic Fibrosis Trust, a national charity based in the UK, in September 2023, there were 11,148 registered patients with cystic fibrosis (CF) in 2022. This figure represents an increase from the 10,908 patients recorded in 2021. Consequently, the increasing occurrence of genetic disorders is stimulating the expansion of the personalized gene therapy treatment market.

What Are The Major Segment Categories Driving The Personalized Gene Therapy Treatment Market Growth?

The personalized gene therapy treatment market covered in this report is segmented as

1) By Therapy: Targeted Treatments, Pharmacogenomics

2) By Vector Type: Viral, Non-Viral

3) By Distribution Channel: Hospitals, Clinics, Home Administration, Other Distribution Channels

4) By Application: Oncology, Neurology, Hematological, Infectious Diseases, Ophthalmology, Other Applications

Subsegments:

1) By Targeted Treatments: Monoclonal Antibodies, Chimeric Antigen Receptor T-Cell Therapy (CAR-T), Small Interfering RNA (siRNA) Therapy, Antisense Oligonucleotides (ASO), Gene Editing Therapy

2) By Pharmacogenomics: Companion Diagnostics, Drug Metabolism Enzyme Testing, Genetic Biomarker Analysis, Single Nucleotide Polymorphism (SNP) Profiling, Adverse Drug Reaction (ADR) Prediction

What Are The Major Trends Driving The Growth Of The Personalized Gene Therapy Treatment Market?

Leading companies in the personalized gene therapy treatment market are increasingly focusing on forming strategic partnerships to enhance their technological capabilities and more effectively deliver innovative therapies to patients. Such strategic partnerships are collaborative alliances between organizations, designed to leverage each other’s strengths and resources for mutual growth and competitive advantage while distributing risks and benefits. For instance, in May 2025, Aldevron, a US-based company involved in DNA, RNA, and protein production, collaborated with Integrated DNA Technologies, a US-based genomics solutions provider. This partnership led to the manufacturing of the world’s first mRNA-based personalized CRISPR therapy, intended to treat an infant with a rare and life-threatening genetic condition known as urea cycle disorder (UCD). This N of 1 therapy was developed and delivered in just six months, achieved by creating a custom guide RNA, an mRNA-encoded base editor, off-target safety services, and a clinically validated lipid nanoparticle delivery system. The development of this therapy marks a significant milestone for personalized in vivo base-editing treatments.

Which Industry Leaders Are Driving Innovation Across The Personalized Gene Therapy Treatment Market?

Major companies operating in the personalized gene therapy treatment market are Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Vertex Pharmaceuticals Incorporated, Kyowa Kirin Co. Ltd., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., Rocket Pharmaceuticals Inc., REGENXBIO Inc., Intellia Therapeutics Inc., Beam Therapeutics Inc., Adaptimmune Therapeutics plc, Krystal Biotech Inc., Miltenyi Biomedicine GmbH, Bluebird Bio Inc., uniQure N.V., Mesoblast Limited, Astellas Gene Therapies Inc., Adverum Biotechnologies Inc., Autolus Therapeutics plc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/personalized-gene-therapy-treatment-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Personalized Gene Therapy Treatment Market?

North America was the largest region in the personalized gene therapy treatment market in 2024. The regions covered in personalized gene therapy treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Personalized Gene Therapy Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28293&type=smp

Browse Through More Reports Similar to the Global Personalized Gene Therapy Treatment Market 2025, By The Business Research Company

Genes Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Nucleic Acid Based Gene Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Cell And Gene Therapy Clinical Trial Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-clinical-trial-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795